ApsTron Science has announced the release of its next-generation physiological sensor platform, aimed at addressing growing global demand for continuous, data-driven health monitoring through wearable technologies. The new platform includes advanced surface electromyography (sEMG), photoplethysmography (PPG), skin temperature, galvanic skin response (GSR) and respiration sensors, each delivered with integrated software to support rapid product development and scalable deployment.
The sensor suite is engineered to deliver high-resolution, real-time physiological data while meeting the power efficiency, size and reliability requirements of modern wearable devices. By enabling multimodal data capture within a unified platform, ApsTron Science is positioning itself to support a wide range of applications across consumer health, remote patient monitoring, digital therapeutics, and clinical research.
The platform’s sEMG sensors are designed for accurate detection of muscle activation, fatigue, and neuromuscular patterns, enabling applications in rehabilitation, physical therapy, sports performance optimisation, ergonomics and neuromuscular diagnostics. The updated PPG sensors provide enhanced measurement of peripheral blood flow, heart rate and inter-beat intervals, supporting cardiovascular monitoring, fitness tracking, recovery analysis; and early detection of physiological changes.
In addition, the skin temperature sensors allow for continuous tracking of subtle temperature variations associated with circadian rhythms, metabolic changes, illness onset, and recovery. The GSR sensors capture electrodermal activity linked to stress, emotional arousal, and autonomic nervous system response, supporting mental health monitoring, stress management tools and wellness analytics. The respiration sensors enable measurement of breathing rate, depth, and variability, with applications spanning sleep analysis, respiratory health, stress detection and chronic disease management.
A core differentiator of the platform is its integrated software layer. Each sensor is delivered with supporting firmware, APIs, and data interfaces designed to streamline integration with wearable hardware, mobile applications, cloud infrastructure, and analytics engines. This end-to-end approach is intended to shorten development timelines, reduce engineering overhead, and enable recurring revenue opportunities through software licensing, data services, and enterprise partnerships.
“Our strategy is to deliver complete physiological sensing platforms rather than isolated components,” said ApsTron Science’s Chief Technology Officer. “By combining high-quality biosignal acquisition with software-ready interfaces, we are enabling scalable solutions that can move efficiently from prototype to commercial deployment.”
According to the company, the platform supports multiple wearable form factors, including patches, bands, and embedded systems; and is designed to scale from research pilots to high-volume commercial products. The company believes this flexibility positions the technology to serve a diverse customer base, including device manufacturers, digital health startups, healthcare organisations and research institutions.
Disclaimer – The details expressed in this post are from the companies responsible for sending this post for publication. This website doesn’t endorse the details published here. Readers are urged to use their own discretion while making a decision about purchasing or using a product/service related to this company, or using this information in any way. There has been no monetary benefit to the Publisher/Editor/Website Owner for publishing this post and the Website Owner takes no responsibility for the impacts of purchasing or using these products/services on the reader, or using this information in any way.
Read more in Technology and Society
Leave a Reply